FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790759546> ?p ?o ?g. }

• W2790759546 endingPage "50" @default.
• W2790759546 startingPage "43" @default.
• W2790759546 abstract "•We identified 5 recipient factors in HCV negative transplant recipients associated with significant morbidity and mortality. •Graft survival within 5 years based on points (any combination) was 77.2% (0–4), 69.1% (5–8) and 57.9% (>8). •In recipients with >8 points, graft survival was 42% (MELD <25) and 50% (MELD 25–35) if donors had donor risk index ≥1.7. •Recipients with ≥5 points: longer hospitalization, more rehab admissions, higher incidence of cardiac disease and CKD. Background and Aims Over the last decade, liver transplantation of sicker, older non-hepatitis C cirrhotics with multiple co-morbidities has increased in the United States. We sought to identify an easily applicable set of recipient factors among HCV negative adult transplant recipients associated with significant morbidity and mortality within five years after liver transplantation. Methods We collected national (n = 31,829, 2002–2015) and center-specific data. Coefficients of relevant recipient factors were converted to weighted points and scaled from 0–5. Recipient factors associated with graft failure included: ventilator support (five patients; hazard ratio [HR] 1.59; 95% CI 1.48–1.72); recipient age >60 years (three patients; HR 1.29; 95% CI 1.23–1.36); hemodialysis (three patients; HR 1.26; 95% CI 1.16–1.37); diabetes (two patients; HR 1.20; 95% CI 1.14–1.27); or serum creatinine ≥1.5 mg/dl without hemodialysis (two patients; HR 1.15; 95% CI 1.09–1.22). Results Graft survival within five years based on points (any combination) was 77.2% (0–4), 69.1% (5–8) and 57.9% (>8). In recipients with >8 points, graft survival was 42% (model for end-stage liver disease [MELD] score <25) and 50% (MELD score 25–35) in recipients receiving grafts from donors with a donor risk index >1.7. In center-specific data within the first year, subjects with ≥5 points (vs. 0–4) had longer hospitalization (11 vs. 8 days, p <0.01), higher admissions for rehabilitation (12.3% vs. 2.7%, p <0.01), and higher incidence of cardiac disease (14.2% vs. 5.3%, p <0.01) and stage 3 chronic kidney disease (78.6% vs. 39.5%, p = 0.03) within five years. Conclusion The impact of co-morbidities in an MELD-based organ allocation system need to be reassessed. The proposed clinical tool may be helpful for center-specific assessment of risk of graft failure in non-HCV patients and for discussion regarding relevant morbidity in selected subsets. Lay summary Over the last decade, liver transplantation of sicker, older patient with multiple co-morbidities has increased. In this study, we show that a set of recipient factors (recipient age >60 years, ventilator status, diabetes, hemodialysis and creatinine >1.5 mg/dl) can help identify patients that may not do well after transplant. Transplanting sicker organs in patients with certain combinations of these characteristics leads to lower survival. Over the last decade, liver transplantation of sicker, older non-hepatitis C cirrhotics with multiple co-morbidities has increased in the United States. We sought to identify an easily applicable set of recipient factors among HCV negative adult transplant recipients associated with significant morbidity and mortality within five years after liver transplantation. We collected national (n = 31,829, 2002–2015) and center-specific data. Coefficients of relevant recipient factors were converted to weighted points and scaled from 0–5. Recipient factors associated with graft failure included: ventilator support (five patients; hazard ratio [HR] 1.59; 95% CI 1.48–1.72); recipient age >60 years (three patients; HR 1.29; 95% CI 1.23–1.36); hemodialysis (three patients; HR 1.26; 95% CI 1.16–1.37); diabetes (two patients; HR 1.20; 95% CI 1.14–1.27); or serum creatinine ≥1.5 mg/dl without hemodialysis (two patients; HR 1.15; 95% CI 1.09–1.22). Graft survival within five years based on points (any combination) was 77.2% (0–4), 69.1% (5–8) and 57.9% (>8). In recipients with >8 points, graft survival was 42% (model for end-stage liver disease [MELD] score <25) and 50% (MELD score 25–35) in recipients receiving grafts from donors with a donor risk index >1.7. In center-specific data within the first year, subjects with ≥5 points (vs. 0–4) had longer hospitalization (11 vs. 8 days, p <0.01), higher admissions for rehabilitation (12.3% vs. 2.7%, p <0.01), and higher incidence of cardiac disease (14.2% vs. 5.3%, p <0.01) and stage 3 chronic kidney disease (78.6% vs. 39.5%, p = 0.03) within five years. The impact of co-morbidities in an MELD-based organ allocation system need to be reassessed. The proposed clinical tool may be helpful for center-specific assessment of risk of graft failure in non-HCV patients and for discussion regarding relevant morbidity in selected subsets." @default.
• W2790759546 created "2018-03-29" @default.
• W2790759546 creator A5001719259 @default.
• W2790759546 creator A5018408079 @default.
• W2790759546 creator A5028926267 @default.
• W2790759546 creator A5041953810 @default.
• W2790759546 creator A5060196987 @default.
• W2790759546 creator A5063705635 @default.
• W2790759546 creator A5085710508 @default.
• W2790759546 creator A5087621810 @default.
• W2790759546 date "2018-07-01" @default.
• W2790759546 modified "2023-10-17" @default.
• W2790759546 title "Recipient characteristics and morbidity and mortality after liver transplantation" @default.
• W2790759546 cites W1487543797 @default.
• W2790759546 cites W1565644342 @default.
• W2790759546 cites W1573204503 @default.
• W2790759546 cites W1575931914 @default.
• W2790759546 cites W1668836244 @default.
• W2790759546 cites W1979066818 @default.
• W2790759546 cites W1997245346 @default.
• W2790759546 cites W2001902984 @default.
• W2790759546 cites W2010884477 @default.
• W2790759546 cites W2037195555 @default.
• W2790759546 cites W2048613643 @default.
• W2790759546 cites W2059700860 @default.
• W2790759546 cites W2060529793 @default.
• W2790759546 cites W2061971113 @default.
• W2790759546 cites W2074141690 @default.
• W2790759546 cites W2094171131 @default.
• W2790759546 cites W2115880608 @default.
• W2790759546 cites W2120070121 @default.
• W2790759546 cites W2132328659 @default.
• W2790759546 cites W2169634314 @default.
• W2790759546 cites W2326124718 @default.
• W2790759546 cites W2915588212 @default.
• W2790759546 cites W2915728992 @default.
• W2790759546 doi "https://doi.org/10.1016/j.jhep.2018.02.004" @default.
• W2790759546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29454069" @default.
• W2790759546 hasPublicationYear "2018" @default.
• W2790759546 type Work @default.
• W2790759546 sameAs 2790759546 @default.
• W2790759546 citedByCount "46" @default.
• W2790759546 countsByYear W27907595462018 @default.
• W2790759546 countsByYear W27907595462019 @default.
• W2790759546 countsByYear W27907595462020 @default.
• W2790759546 countsByYear W27907595462021 @default.
• W2790759546 countsByYear W27907595462022 @default.
• W2790759546 countsByYear W27907595462023 @default.
• W2790759546 crossrefType "journal-article" @default.
• W2790759546 hasAuthorship W2790759546A5001719259 @default.
• W2790759546 hasAuthorship W2790759546A5018408079 @default.
• W2790759546 hasAuthorship W2790759546A5028926267 @default.
• W2790759546 hasAuthorship W2790759546A5041953810 @default.
• W2790759546 hasAuthorship W2790759546A5060196987 @default.
• W2790759546 hasAuthorship W2790759546A5063705635 @default.
• W2790759546 hasAuthorship W2790759546A5085710508 @default.
• W2790759546 hasAuthorship W2790759546A5087621810 @default.
• W2790759546 hasConcept C120665830 @default.
• W2790759546 hasConcept C121332964 @default.
• W2790759546 hasConcept C126322002 @default.
• W2790759546 hasConcept C134018914 @default.
• W2790759546 hasConcept C141071460 @default.
• W2790759546 hasConcept C207103383 @default.
• W2790759546 hasConcept C2776455275 @default.
• W2790759546 hasConcept C2777075537 @default.
• W2790759546 hasConcept C2778063415 @default.
• W2790759546 hasConcept C2779250428 @default.
• W2790759546 hasConcept C2779609443 @default.
• W2790759546 hasConcept C2780306776 @default.
• W2790759546 hasConcept C2911091166 @default.
• W2790759546 hasConcept C44249647 @default.
• W2790759546 hasConcept C555293320 @default.
• W2790759546 hasConcept C61511704 @default.
• W2790759546 hasConcept C71924100 @default.
• W2790759546 hasConcept C90924648 @default.
• W2790759546 hasConceptScore W2790759546C120665830 @default.
• W2790759546 hasConceptScore W2790759546C121332964 @default.
• W2790759546 hasConceptScore W2790759546C126322002 @default.
• W2790759546 hasConceptScore W2790759546C134018914 @default.
• W2790759546 hasConceptScore W2790759546C141071460 @default.
• W2790759546 hasConceptScore W2790759546C207103383 @default.
• W2790759546 hasConceptScore W2790759546C2776455275 @default.
• W2790759546 hasConceptScore W2790759546C2777075537 @default.
• W2790759546 hasConceptScore W2790759546C2778063415 @default.
• W2790759546 hasConceptScore W2790759546C2779250428 @default.
• W2790759546 hasConceptScore W2790759546C2779609443 @default.
• W2790759546 hasConceptScore W2790759546C2780306776 @default.
• W2790759546 hasConceptScore W2790759546C2911091166 @default.
• W2790759546 hasConceptScore W2790759546C44249647 @default.
• W2790759546 hasConceptScore W2790759546C555293320 @default.
• W2790759546 hasConceptScore W2790759546C61511704 @default.
• W2790759546 hasConceptScore W2790759546C71924100 @default.
• W2790759546 hasConceptScore W2790759546C90924648 @default.
• W2790759546 hasIssue "1" @default.
• W2790759546 hasLocation W27907595461 @default.
• W2790759546 hasLocation W27907595462 @default.
• W2790759546 hasOpenAccess W2790759546 @default.
• W2790759546 hasPrimaryLocation W27907595461 @default.

• next